Blog
RSS FeedPosted by Michael Wonder on 14 Feb 2022
Peter paid $60,000 to boost his cancer survival chances, but others miss out
15 February 2022 - Some cancer patients are dipping into their superannuation to pay for treatments under a “two-tiered system” ...
Posted by Michael Wonder on 13 Feb 2022
Novavax – first protein vaccine now available
11 February 2022 - Australia’s first protein vaccine, Novavax will join the national rollout from Monday through select general practices, community ...
Posted by Michael Wonder on 11 Feb 2022
Agenda for the May 2022 PBAC intracycle meeting
11 February 2022 - The agenda for the May 2022 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 10 Feb 2022
National Medicines Policy too important to be rushed before Federal Election
10 February 2022 - Following consultation with members – and heeding the concerns of the Consumers Health Forum and patient ...
Posted by Michael Wonder on 09 Feb 2022
Women in Dobell can’t afford medicine
8 February 2022 - A third of women living in the federal electorate of Dobell struggle to afford prescription medicines, ...
Posted by Michael Wonder on 08 Feb 2022
Pharmacist substitution of PBS medicines without a prescription during shortages (Serious Scarcity Substitution Instrument) - 8 February 2022
8 February 2022 - From 8 February 2022, abatacept syringe (Orencia) and abatacept auto-injector (Orencia ClickJect) can be interchangeably substituted ...
Posted by Michael Wonder on 07 Feb 2022
Review of the National Medicines Policy – consultation on draft National Medicines Policy extended
8 February 2022 - The consultation period on the draft NMP was due to close on Wednesday 16 February 2022. ...
Posted by Michael Wonder on 07 Feb 2022
Mentoring as a potential means to assist consumer representatives contribute effectively to the assessment of health technologies in Australia: a pragmatic review
7 February 2022 - This project was implemented on behalf of the Health Technology Assessment Consumer Consultative Committee to explore training ...
Posted by Michael Wonder on 07 Feb 2022
Analysis of consumer comments into PBAC decision-making (2014–9)
4 February 2022 - Our objective was to analyse and review consumer comments in the PBAC's decision-making process. ...
Posted by Michael Wonder on 07 Feb 2022
DoH publishes revised agenda for next month's PBAC meeting
7 February 2022 - The revised agenda notes three changes. ...
Posted by Michael Wonder on 07 Feb 2022
Medicines Australia calls for new National Medicines Policy to be pushed back until after the federal election
4 February 2022 - Medicines Australia is today calling for the new National Medicines Policy to be pushed back until ...
Posted by Michael Wonder on 03 Feb 2022
Stakeholder consultation forum: post-market review of opiate dependence treatment program medicines
3 February 2022 - A stakeholder consultation forum for the post-market review of opiate dependence treatment program medicines will be ...
Posted by Michael Wonder on 03 Feb 2022
Eligible Australian kids 16+ can now get a booster
3 February 2022 - From today, eligible Australians aged 16 and 17 years old will be able to receive a COVID-19 ...
Posted by Michael Wonder on 02 Feb 2022
Review of the National Medicines Policy – consultation on the draft closes 16 February 2022
2 February 2022 - Since August 2021, the Committee has heard from nearly 200 stakeholders through bilateral interviews and virtual group ...
Posted by Michael Wonder on 01 Feb 2022
'Lifesaving' cystic fibrosis drug Trikafta recommended for inclusion on PBS
1 February 2022 - Thousands of people with cystic fibrosis are one step closer to accessing a 'lifesaving' drug, after ...